{"disease":{"id":"vaginosis","name":"vaginosis"},"drugs":{"marketed":[{"drug_id":"tinidazole","indication_name":"Bacterial Vaginosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tindamax","generic_name":"TINIDAZOLE","company_name":"Mission Pharma","drug_phase":"marketed","molecular_target":"","drug_class":"Nitroimidazole Antimicrobial [EPC]","quality_score":65,"revenue":null,"mechanism":"Tindamax works by damaging the DNA of susceptible microorganisms, ultimately leading to their death."},{"drug_id":"sulfacetamide","indication_name":"Gardnerella Vaginalis Bacterial Vaginosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Klaron","generic_name":"SULFACETAMIDE","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Dihydrofolate reductase","drug_class":"Sulfonamide Antibacterial","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"clindamycin","indication_name":"Bacterial vaginosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cleocin","generic_name":"clindamycin","company_name":"Generic (originally Upjohn/Pfizer)","drug_phase":"marketed","molecular_target":"50S ribosomal protein L10","drug_class":"Lincosamide antibiotic","quality_score":56,"revenue":null,"mechanism":"Lincosamide antibiotic that binds the 50S ribosomal subunit, inhibiting bacterial protein synthesis with excellent anaerobic coverage."},{"drug_id":"metronidazole","indication_name":"Bacterial vaginosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Metro I.V. In Plastic Container","generic_name":"METRONIDAZOLE","company_name":"Baxter","drug_phase":"marketed","molecular_target":"","drug_class":"Nitroimidazole Antimicrobial [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"tinidazole","indication_name":"Bacterial vaginosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tindamax","generic_name":"TINIDAZOLE","company_name":"Mission Pharma","drug_phase":"marketed","molecular_target":"","drug_class":"Nitroimidazole Antimicrobial [EPC]","quality_score":65,"revenue":null,"mechanism":"Tindamax works by damaging the DNA of susceptible microorganisms, ultimately leading to their death."},{"drug_id":"sulfabenzamide","indication_name":"Gardnerella Vaginalis Bacterial Vaginosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Sulfabenzid","generic_name":"SULFABENZAMIDE","company_name":"Johnson & Johnson","drug_phase":"marketed","molecular_target":"","drug_class":"sulfabenzamide","quality_score":20,"revenue":null,"mechanism":""},{"drug_id":"secnidazole","indication_name":"Bacterial vaginosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Solosec","generic_name":"SECNIDAZOLE","company_name":"Evofem Inc","drug_phase":"marketed","molecular_target":"","drug_class":"Nitroimidazole Antimicrobial [EPC]","quality_score":10,"revenue":null,"mechanism":"Solosec works by entering susceptible microorganisms and disrupting their DNA, ultimately leading to cell death."},{"drug_id":"metronidazol","indication_name":"Bacterial vaginosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Metronidazol","company_name":"University of Oslo","drug_phase":"marketed","molecular_target":"Thioredoxin reductase","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":8,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06472765","title":"Vaginal Ecosystem and Network in the United States Study","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":3250,"lead_sponsor_name":"Vaginal Biome Science","has_results":false},{"nct_id":"NCT00667368","title":"Bacterial Vaginosis Home Screening to Prevent STDs","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1370,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT06530186","title":"Evaluation of a Postcoital Sponge on Self-Reported Vaginal Health Parameters","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Atlantic Health System","has_results":false},{"nct_id":"NCT03091777","title":"Study Evaluating the Equivalence of GDC-229 and Metronidazole Vaginal Gel 0.75% in the Treatment of Bacterial Vaginosis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":871,"lead_sponsor_name":"Balmoral Medical company","has_results":true},{"nct_id":"NCT06975436","title":"Performance Study of the Cobas® BV/CV Test on Samples From Participants With and Without Symptoms of Bacterial Vaginosis and Candida Vaginitis","phase":"","overall_status":"COMPLETED","enrollment_count":738,"lead_sponsor_name":"Hoffmann-La Roche","has_results":false},{"nct_id":"NCT03045809","title":"Women's Improvement of Sexual Health (WISH) Demonstration Project","phase":"","overall_status":"COMPLETED","enrollment_count":705,"lead_sponsor_name":"Janneke van de Wijgert","has_results":true},{"nct_id":"NCT02236156","title":"Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":637,"lead_sponsor_name":"Starpharma Pty Ltd","has_results":false},{"nct_id":"NCT06154239","title":"Screening With Tampons: Evaluating Diagnostic Accuracy and HPV and Assessing Participant Views","phase":"NA","overall_status":"COMPLETED","enrollment_count":617,"lead_sponsor_name":"Anne's Day Ltd","has_results":false},{"nct_id":"NCT06131749","title":"Genital Tract Infections, the Vaginal Microbiome and Gestational Age at Birth Among Pregnant Women in South Africa","phase":"","overall_status":"COMPLETED","enrollment_count":603,"lead_sponsor_name":"University of Bern","has_results":false},{"nct_id":"NCT03917134","title":"Prevention of Vaginal Cellulitis or Vaginal Cuff Abscess After Laparoscopic Hysterectomy","phase":"NA","overall_status":"UNKNOWN","enrollment_count":600,"lead_sponsor_name":"CES University","has_results":false},{"nct_id":"NCT02237950","title":"Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":586,"lead_sponsor_name":"Starpharma Pty Ltd","has_results":true},{"nct_id":"NCT06056947","title":"Evaluation of Efficacy and Safety of Two New Formulations Compared to Gynomax® XL Ovule","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":577,"lead_sponsor_name":"Ege University","has_results":false},{"nct_id":"NCT03303859","title":"Bacterial Vaginosis Carriage in Early Pregnancy and Preterm Delivery in Martinique, F.W.I","phase":"","overall_status":"COMPLETED","enrollment_count":511,"lead_sponsor_name":"University Hospital Center of Martinique","has_results":false},{"nct_id":"NCT05666778","title":"Single Arm Trial of Menstrual Cups Among Economically Vulnerable Women to Reduce Bacterial Vaginosis and STIs","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":408,"lead_sponsor_name":"Rush University Medical Center","has_results":false},{"nct_id":"NCT07418957","title":"Efficacy and Safety of Vaginal Lactobacillus Dual Probiotic Capsules in Bacterial Vaginosis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":402,"lead_sponsor_name":"Guangdong Longchuangji Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT06438575","title":"Point of Care Diagnosis of Vaginal Infections","phase":"NA","overall_status":"COMPLETED","enrollment_count":351,"lead_sponsor_name":"Sharon L Hillier","has_results":true},{"nct_id":"NCT04370548","title":"DARE-BV1 in the Treatment of Bacterial Vaginosis (DARE-BVFREE)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":307,"lead_sponsor_name":"Daré Bioscience, Inc.","has_results":true},{"nct_id":"NCT04171947","title":"Vaginal Ovule With Flavonoid Tea Extract for the Correction of Imbalance in the Vaginal Environment","phase":"NA","overall_status":"COMPLETED","enrollment_count":274,"lead_sponsor_name":"Value Outcomes Ltd.","has_results":false},{"nct_id":"NCT01577537","title":"A Phase 3 Study of SPL7013 Gel (VivaGel) for the Treatment of Bacterial Vaginosis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":251,"lead_sponsor_name":"Starpharma Pty Ltd","has_results":true},{"nct_id":"NCT02905890","title":"The Effect of Norethisterone Enanthate on Recurrent Bacterial Vaginosis","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":250,"lead_sponsor_name":"London School of Hygiene and Tropical Medicine","has_results":false},{"nct_id":"NCT01577238","title":"A Phase 3 Study of SPL7013 Gel (VivaGel) for the Treatment of Bacterial Vaginosis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":250,"lead_sponsor_name":"Starpharma Pty Ltd","has_results":true},{"nct_id":"NCT02766023","title":"LACTIN-V Study for Recurrent Bacterial Vaginosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":228,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT04219605","title":"Evaluation of a Rapid Microscopic Diagnostic System for Different Vaginitis Conditions","phase":"","overall_status":"COMPLETED","enrollment_count":226,"lead_sponsor_name":"Meir Medical Center","has_results":false},{"nct_id":"NCT05796921","title":"Lacticaseibacillus Rhamnosus CA15 (DSM 33960) Strain as a New Driver in Restoring the Normal Vaginal Microbiota","phase":"NA","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Agnese Maria Chiara Rapisarda","has_results":false},{"nct_id":"NCT06616168","title":"Urogenital Infections in Women of Reproductive Age and the Activity of 4-Thiazolidinone Derivatives Against Pathogens","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":200,"lead_sponsor_name":"Danylo Halytsky Lviv National Medical University","has_results":false},{"nct_id":"NCT02946346","title":"Kinetics and Ecology of Human Papillomavirus Genital Infections in Young Women","phase":"NA","overall_status":"TERMINATED","enrollment_count":190,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT02418845","title":"A Phase 3 Study of SYM-1219 Treatment of Women and Post-Menarchal Adolescent Girls With Bacterial Vaginosis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":189,"lead_sponsor_name":"Symbiomix Therapeutics","has_results":true},{"nct_id":"NCT03601429","title":"Dietary Supplementation of Lactogyn in Women With Bacterial Vaginosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":166,"lead_sponsor_name":"Vesale Pharmaceutica","has_results":false},{"nct_id":"NCT06450990","title":"Efficacy, Safety, and Dose-response of a Live Biotherapeutic Product in Women With Acute Vaginal Infection","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":165,"lead_sponsor_name":"NEXBIOME THERAPEUTICS","has_results":false},{"nct_id":"NCT07527572","title":"Study to Evaluate Efficacy and Safety of Gyntima® Balance in Preventing Recurrences of Bacterial Vaginosis","phase":"PHASE2, PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":160,"lead_sponsor_name":"Kaneka Americas Holding Inc.","has_results":false},{"nct_id":"NCT07474831","title":"Evaluation of the Ability of Lactobacillus Crispatus CRP21 to Reduce the Incidence of Recurrent Bacterial Vaginosis","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":156,"lead_sponsor_name":"Liaquat University of Medical & Health Sciences","has_results":false},{"nct_id":"NCT04640922","title":"Clinical Performance and Safety of the Gedea Pessary in Adult Women With Bacterial Vaginosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":152,"lead_sponsor_name":"Gedea Biotech AB","has_results":false},{"nct_id":"NCT05788991","title":"Comparison of Dequalinium Chloride (Fluomizin) vs Oral Metronidazole for the Treatment of Bacterial Vaginosis","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":151,"lead_sponsor_name":"Medinova AG","has_results":true},{"nct_id":"NCT04771728","title":"A Prospective, Randomized Controlled Study of the Probiotics as Adjuvant Treatment for Bacterial Vaginosis","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":140,"lead_sponsor_name":"Peking University Shenzhen Hospital","has_results":false},{"nct_id":"NCT03134924","title":"Vaginal Practices in Human Immunodeficiency Virus (HIV) Positive Women in Zambia, a Bio-Behavioral Intervention \"WASH-2\"","phase":"NA","overall_status":"COMPLETED","enrollment_count":128,"lead_sponsor_name":"University of Miami","has_results":false},{"nct_id":"NCT03894813","title":"Probiotics as Adjuvant Treatment for Bacterial Vaginosis","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":126,"lead_sponsor_name":"Peking University Shenzhen Hospital","has_results":true},{"nct_id":"NCT06592976","title":"Effects of a Multi-strain Oral Probiotic on the Vaginal Microbiota Composition in Healthy Women and Women with Endometriosis","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":123,"lead_sponsor_name":"University of Roma La Sapienza","has_results":false},{"nct_id":"NCT06665126","title":"A Study to Evaluate the Effects of a Prebiotic and Probiotic Supplement to Provide Relief From Symptoms Associated With Bacterial Vaginosis and Yeast Infections.","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":120,"lead_sponsor_name":"Happy V","has_results":false},{"nct_id":"NCT07481955","title":"Chlorhexidine and/or Metronidazole Plus FB301 Pre-treatment Trial","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":120,"lead_sponsor_name":"Freya Biosciences ApS","has_results":false},{"nct_id":"NCT06263465","title":"Precision Vaginal Microbiome Transplantation in Women With Bacterial Vaginosis","phase":"NA","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Zhujiang Hospital","has_results":false},{"nct_id":"NCT03839875","title":"Evaluation of Efficacy and Safety of Gynomax® XL Ovule","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":116,"lead_sponsor_name":"Exeltis Turkey","has_results":false},{"nct_id":"NCT05652959","title":"Real-world Performance and Safety of Cerviron® in the Treatment of Vaginitis","phase":"","overall_status":"COMPLETED","enrollment_count":111,"lead_sponsor_name":"Perfect Care Distribution","has_results":false},{"nct_id":"NCT02709005","title":"Safety and Efficacy of 5% Monolaurin Vaginal Gel Administered Intravaginally for the Treatment of Bacterial Vaginosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":109,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT02866227","title":"TOL-463 Phase 2 Study for Vaginitis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":106,"lead_sponsor_name":"Toltec Pharmaceuticals, LLC","has_results":false},{"nct_id":"NCT06469164","title":"A First-in-human Safety Trial of BNT331 Administered as Single Ascending Doses in Healthy Women and as Multiple Ascending Doses in Women Diagnosed With Bacterial Vaginosis","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":102,"lead_sponsor_name":"BioNTech SE","has_results":false},{"nct_id":"NCT07247851","title":"Title of the Protocol: Combined Use of Vaginal Clindamycin Cream and Oral Metronidazole Versus Oral Metronidazole","phase":"NA","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Ain Shams Maternity Hospital","has_results":false},{"nct_id":"NCT06458543","title":"Optimization of Bacterial Vaginosis Treatment in Women of Reproductive Age","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"I.M. Sechenov First Moscow State Medical University","has_results":false},{"nct_id":"NCT05649735","title":"EFFICACY AND SAFETY OF OVA AND LAVAGE MEDICAL DEVICES IN THE TREATMENT OF NON-SPECIFIC VULVOVAGINITIS","phase":"NA","overall_status":"COMPLETED","enrollment_count":91,"lead_sponsor_name":"Ospedale del Mare","has_results":false},{"nct_id":"NCT04489290","title":"Efficacy and Safety of D005 Vaginal Mousse on Bacterial Vaginosis","phase":"NA","overall_status":"UNKNOWN","enrollment_count":83,"lead_sponsor_name":"PepTonic Medical AB","has_results":false},{"nct_id":"NCT03930745","title":"Suppression Of Bacterial Vaginosis (BV) [SUBVert]","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":81,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}